相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bromodomain and extra-terminal motif (BET) inhibition is synthetic lethal with loss of SMAD4 in colorectal cancer cells via restoring the loss of MYC repression
Changxiang Shi et al.
ONCOGENE (2021)
Class I histone deacetylase inhibition is synthetic lethal with BRCA1 deficiency in breast cancer cells
Baoyuan Zhang et al.
ACTA PHARMACEUTICA SINICA B (2020)
Somatic selection distinguishes oncogenes and tumor suppressor genes
Pramod Chandrashekar et al.
BIOINFORMATICS (2020)
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers
Florence Coussy et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
A Phase 1 Study of SLC-0111, a Novel Inhibitor of Carbonic Anhydrase IX, in Patients With Advanced Solid Tumors
Paul C. McDonald et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2020)
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2020)
Targeting β-Catenin Signaling by Natural Products for Cancer Prevention and Therapy
Wen-Kai Yu et al.
FRONTIERS IN PHARMACOLOGY (2020)
Synthetic Lethal Activity of Benzophenanthridine Alkaloids From Zanthoxylum coco Against BRCA1-Deficient Cancer Cells
Iris A. Garcia et al.
FRONTIERS IN PHARMACOLOGY (2020)
Antitumor functions and mechanisms of nitidine chloride in human cancers
Yue Cui et al.
JOURNAL OF CANCER (2020)
Creating and screening natural product libraries
Brice A. P. Wilson et al.
NATURAL PRODUCT REPORTS (2020)
AKT inhibition impairs PCNA ubiquitylation and triggers synthetic lethality in homologous recombination-deficient cells submitted to replication stress
Florencia Villafanez et al.
ONCOGENE (2019)
Nitidine Chloride Inhibits SIN1 Expression in Osteosarcoma Cells
Hui Xu et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction
Sofia Carbajosa et al.
CLINICAL CANCER RESEARCH (2019)
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens
Fiona M. Behan et al.
NATURE (2019)
FDA-approved drug screen identifies proteasome as a synthetic lethal target in MYC-driven neuroblastoma
Jingchao Wang et al.
ONCOGENE (2019)
MiR223-3p promotes synthetic lethality in BRCA1-deficient cancers
Gayathri Srinivasan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
High throughput circRNA sequencing analysis reveals novel insights into the mechanism of nitidine chloride against hepatocellular carcinoma
Dan-dan Xiong et al.
CELL DEATH & DISEASE (2019)
Nitidine chloride exerts anti-inflammatory action by targeting Topoisomerase I and enhancing IL-10 production
Niao Yang et al.
PHARMACOLOGICAL RESEARCH (2019)
CD36 inhibits β-catenin/c-myc-mediated glycolysis through ubiquitination of GPC4 to repress colorectal tumorigenesis
Yuan Fang et al.
NATURE COMMUNICATIONS (2019)
A high-throughput screen to identify novel synthetic lethal compounds for the treatment of E-cadherin-deficient cells
Henry Beetham et al.
SCIENTIFIC REPORTS (2019)
Precision medicine in gastric cancer
Patrizia Bonelli et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)
The immunoregulatory protein B7-H3 promotes aerobic glycolysis in oral squamous carcinoma via PI3K/Akt/mTOR pathway
Zhangao Li et al.
JOURNAL OF CANCER (2019)
Diverse Therapeutic Potential of Nitidine, A Comprehensive Review
Haroon Khan et al.
CURRENT DRUG METABOLISM (2018)
Nitidine chloride represses Mcl-1 protein via lysosomal degradation in oral squamous cell carcinoma
In-Hyoung Yang et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2018)
Cell Cycle Arrest and Apoptosis Induction Activity of Nitidine Chloride on Acute Myeloid Leukemia Cells
Peng Li et al.
MEDICINAL CHEMISTRY (2018)
Precision Medicine and Radiogenomics in Breast Cancer: New Approaches toward Diagnosis and Treatment
Katja Pinker et al.
RADIOLOGY (2018)
BRCA1 deficiency sensitizes breast cancer cells to bromodomain and extra-terminal domain (BET) inhibition
Baoyuan Zhang et al.
ONCOGENE (2018)
Ionophores: Potential Use as Anticancer Drugs and Chemosensitizers
Vivek Kaushik et al.
CANCERS (2018)
Inhibition of AKT suppresses the initiation and progression of BRCA1-associated mammary tumors
Hye Jung Baek et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Cancer metabolism: a therapeutic perspective
Ubaldo E. Martinez-Outschoorn et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Aerobic Glycolysis Hypothesis Through WNT/Beta-Catenin Pathway in Exudative Age-Related Macular Degeneration
Alexandre Vallee et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2017)
Englerins: A Comprehensive Review
Zhenhua Wu et al.
JOURNAL OF NATURAL PRODUCTS (2017)
Synthetic lethality and cancer
Nigel J. O'Neil et al.
NATURE REVIEWS GENETICS (2017)
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia
Andreas Hochhaus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
ATM loss leads to synthetic lethality in BRCA1 BRCT mutant mice associated with exacerbated defects in homology-directed repair
Chun-Chin Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
PARP inhibitors: Synthetic lethality in the clinic
Christopher J. Lord et al.
SCIENCE (2017)
A Small Molecule Inhibitor of the β-Catenin-TCF4 Interaction Suppresses Colorectal Cancer Growth In Vitro and In Vivo
Seung Ho Shin et al.
EBIOMEDICINE (2017)
A Novel Cellular Spheroid-Based Autophagy Screen Applying Live Fluorescence Microscopy Identifies Nonactin as a Strong Inducer of Autophagosomal Turnover
Francesco Pampaloni et al.
SLAS DISCOVERY (2017)
Englerin A induces an acute inflammatory response and reveals lipid metabolism and ER stress as targetable vulnerabilities in renal cell carcinoma
Ayse Batova et al.
PLOS ONE (2017)
Nitidine chloride inhibited the expression of S phase kinase-associated protein 2 in ovarian cancer cells
Huaping Mou et al.
CELL CYCLE (2017)
Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening
E. Robert McDonald et al.
CELL (2017)
Mitochondrial uncoupler exerts a synthetic lethal effect against -catenin mutant tumor cells
Yuki Shikata et al.
CANCER SCIENCE (2017)
Unveiling (-)-EnglerinA as a Modulator of L-Type Calcium Channels
Tiago Rodrigues et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Synthesis of a stable and orally bioavailable englerin analogue
David M. Fash et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Role of OCT2 and MATE1 in renal disposition and toxicity of nitidine chloride
L. P. Li et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Nitidine chloride inhibits proliferation and induces apoptosis in colorectal cancer cells by suppressing the ERK signaling pathway
Huiyuan Zhai et al.
MOLECULAR MEDICINE REPORTS (2016)
Counting on natural products for drug design
Tiago Rodrigues et al.
NATURE CHEMISTRY (2016)
Nitidine chloride inhibits the malignant behavior of human glioblastoma cells by targeting the PI3K/AKT/mTOR signaling pathway
Ming Liu et al.
ONCOLOGY REPORTS (2016)
The Warburg Effect: How Does it Benefit Cancer Cells?
Maria V. Liberti et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Hedgehog pathway is involved in nitidine chloride induced inhibition of epithelial-mesenchymal transition and cancer stem cells-like properties in breast cancer cells
Mingjuan Sun et al.
CELL AND BIOSCIENCE (2016)
A novel cell-penetrating peptide suppresses breast tumorigenesis by inhibiting β-catenin/LEF-1 signaling
Tsung-Hua Hsieh et al.
SCIENTIFIC REPORTS (2016)
(-)-Englerin A is a Potent and Selective Activator of TRPC4 and TRPC5 Calcium Channels
Yasemin Akbulut et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Synthetic Lethality and Cancer Therapy: Lessons Learned from the Development of PARP Inhibitors
Christopher J. Lord et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
Padmanee Sharma et al.
CELL (2015)
The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer
Tian-Lin He et al.
MEDICAL ONCOLOGY (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
7Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors
Maria Teresa Esposito et al.
NATURE MEDICINE (2015)
DNA polymerase θ—a new target for synthetic lethality?
David Killock
Nature Reviews Clinical Oncology (2015)
Personalised cancer medicine
Sarah E. Jackson et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy
Nada Albarakati et al.
MOLECULAR ONCOLOGY (2015)
Novel Agent Nitidine Chloride Induces Erythroid Differentiation and Apoptosis in CML Cells through c-Myc-miRNAs Axis
Na Liu et al.
PLOS ONE (2015)
Englerin A Agonizes the TRPC4/C5 Cation Channels to Inhibit Tumor Cell Line Proliferation
Cheryl Carson et al.
PLOS ONE (2015)
VHL, the story of a tumour suppressor gene
Lucy Gossage et al.
NATURE REVIEWS CANCER (2015)
Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer
Julius Chapiro et al.
CLINICAL CANCER RESEARCH (2014)
Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer
Kira T. Pate et al.
EMBO JOURNAL (2014)
The Contribution of Human OCT1, OCT3, and CYP3A4 to Nitidine Chloride-Induced Hepatocellular Toxicity
Liping Li et al.
DRUG METABOLISM AND DISPOSITION (2014)
Rational Design of Small-Molecule Inhibitors for β-Catenin/T-Cell Factor Protein-Protein Interactions by Bioisostere Replacement
Binxun Yu et al.
ACS CHEMICAL BIOLOGY (2013)
Englerin A Stimulates PKCθ to Inhibit Insulin Signaling and to Simultaneously Activate HSF1: Pharmacologically Induced Synthetic Lethality
Carole Sourbier et al.
CANCER CELL (2013)
A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors
Luis E. Raez et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Nitidine chloride inhibits renal cancer cell metastasis via suppressing AKT signaling pathway
Zhiqing Fang et al.
FOOD AND CHEMICAL TOXICOLOGY (2013)
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
Gregg L. Semenza
JOURNAL OF CLINICAL INVESTIGATION (2013)
Renal cancer-selective Englerin A induces multiple mechanisms of cell death and autophagy
Richard T. Williams et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying et al.
CELL (2012)
Inhibition of STAT3 Signaling Pathway by Nitidine Chloride Suppressed the Angiogenesis and Growth of Human Gastric Cancer
Jing Chen et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Biological activities of nitidine, a potential antimalarial lead compound
Jerome Bouquet et al.
MALARIA JOURNAL (2012)
Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes
Zhi Jiang Zang et al.
NATURE GENETICS (2012)
Inhibition of oncogenic Wnt signaling through direct targeting of β-catenin
Tom N. Grossmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Trastuzumab containing regimens for early breast cancer
Lorenzo Moja et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
HIF1 alpha and HIF2 alpha: sibling rivalry in hypoxic tumour growth and progression
Brian Keith et al.
NATURE REVIEWS CANCER (2012)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rad52 inactivation is synthetically lethal with BRCA2 deficiency
Zhihui Feng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Total Synthesis of Englerin A
K. C. Nicolaou et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
M. William Audeh et al.
LANCET (2010)
Targeting Tumor Metabolism With 2-Deoxyglucose in Patients With Castrate-Resistant Prostate Cancer and Advanced Malignancies
Mark Stein et al.
PROSTATE (2010)
Nonactin biosynthesis: Setting limits on what can be achieved with precursor-directed biosynthesis
Brian R. Kusche et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Alternating Pattern of Stereochemistry in the Nonactin Macrocycle Is Required for Antibacterial Activity and Efficient Ion Binding
Brian R. Kusche et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Englerin A, a Selective Inhibitor of Renal Cancer Cell Growth, from Phyllanthus engleri
Ranjala Ratnayake et al.
ORGANIC LETTERS (2009)
Wnt signalling and its impact on development and cancer
Alexandra Klaus et al.
NATURE REVIEWS CANCER (2008)
Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis
Chengkai Dai et al.
CELL (2007)
Utilizing RNA interference to enhance cancer drug discovery
Elizabeth Iorns et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Rapid structural characterization of isomeric benzo[c]phenanthridine alkaloids from the roots of Zanthoxylum nitidium by liquid chromatography combined with electrospray ionization tandem mass spectrometry
Min Cai et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2007)
Synthesis of nonactin and the proposed structure of trilactone
Yikang Wu et al.
ORGANIC LETTERS (2006)
High-throughput RNAi screening in cultured cells: a user's guide
CJ Echeverri et al.
NATURE REVIEWS GENETICS (2006)
Benzophenanthridine alkaloids from Zanthoxylum nitidum (ROXB.) DC, and their analgesic and anti-inflammatory activities
Jiang Hu et al.
CHEMISTRY & BIODIVERSITY (2006)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Systematic peptide array-based delineation of the differential β-catenin interaction with Tcf4, E-cadherin, and adenomatous polyposis coli
R Gail et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
We of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage
K Yoshida et al.
CANCER SCIENCE (2004)
Protein kinase C θ inhibits insulin signaling by phosphorylating IRS1 at Ser1101
Y Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Nonactin biosynthesis: The initial committed step is the condensation of acetate (malonate) and succinate
ME Nelson et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2002)
分享论文
